ARCHIVES

Gregory Reaman Named Associate Director of FDA Office of Oncology Drug Products

This article is from The Cancer Letter archive.

Vol. 37 No. 22 | June 3, 2011

Download PDF Visit The Full Archive

Related Articles

Senate Resolution Urges CMS To Reopen Coverage Policy on ESAs In Oncology.

September 7, 2007

NIH to Hold Meeting On Faculty Design

February 2, 1996

Book For Survivors, Other New Publications

August 23, 1991

Rituxan Approved as Maintenance For Advanced Follicular Lymphoma

February 25, 2011

In Brief: NCAB Committee Recommends Joint NCI/Vendor PDQ Promotion; Frank Schabel Dies In Vienna

September 9, 1983

In Brief: NCA to Hear Reports On Outstanding Investigator Awards, Defining QRA, P01 Guidelines, Gallow Work

May 6, 1983